Literature DB >> 30647103

Extracellular Fatty Acids Are the Major Contributor to Lipid Synthesis in Prostate Cancer.

Seher Balaban1, Zeyad D Nassar2,3, Alison Y Zhang4,5,6, Elham Hosseini-Beheshti1, Margaret M Centenera2,3, Mark Schreuder1,7, Hui-Ming Lin4, Atqiya Aishah1, Bianca Varney1, Frank Liu-Fu1, Lisa S Lee1, Shilpa R Nagarajan1, Robert F Shearer4, Rae-Anne Hardie5,8, Nikki L Raftopulos1, Meghna S Kakani1, Darren N Saunders9, Jeff Holst5,8, Lisa G Horvath4,5,6,10,11, Lisa M Butler2,3, Andrew J Hoy12.   

Abstract

Prostate cancer cells exhibit altered cellular metabolism but, notably, not the hallmarks of Warburg metabolism. Prostate cancer cells exhibit increased de novo synthesis of fatty acids (FA); however, little is known about how extracellular FAs, such as those in the circulation, may support prostate cancer progression. Here, we show that increasing FA availability increased intracellular triacylglycerol content in cultured patient-derived tumor explants, LNCaP and C4-2B spheroids, a range of prostate cancer cells (LNCaP, C4-2B, 22Rv1, PC-3), and prostate epithelial cells (PNT1). Extracellular FAs are the major source (∼83%) of carbons to the total lipid pool in all cell lines, compared with glucose (∼13%) and glutamine (∼4%), and FA oxidation rates are greater in prostate cancer cells compared with PNT1 cells, which preferentially partitioned extracellular FAs into triacylglycerols. Because of the higher rates of FA oxidation in C4-2B cells, cells remained viable when challenged by the addition of palmitate to culture media and inhibition of mitochondrial FA oxidation sensitized C4-2B cells to palmitate-induced apoptosis. Whereas in PC-3 cells, palmitate induced apoptosis, which was prevented by pretreatment of PC-3 cells with FAs, and this protective effect required DGAT-1-mediated triacylglycerol synthesis. These outcomes highlight for the first-time heterogeneity of lipid metabolism in prostate cancer cells and the potential influence that obesity-associated dyslipidemia or host circulating has on prostate cancer progression. IMPLICATIONS: Extracellular-derived FAs are primary building blocks for complex lipids and heterogeneity in FA metabolism exists in prostate cancer that can influence tumor cell behavior. ©2019 American Association for Cancer Research.

Entities:  

Year:  2019        PMID: 30647103     DOI: 10.1158/1541-7786.MCR-18-0347

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  22 in total

Review 1.  Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.

Authors:  Lisa M Butler; Ylenia Perone; Jonas Dehairs; Leslie E Lupien; Vincent de Laat; Ali Talebi; Massimo Loda; William B Kinlaw; Johannes V Swinnen
Journal:  Adv Drug Deliv Rev       Date:  2020-07-23       Impact factor: 15.470

Review 2.  Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Medicines (Basel)       Date:  2019-07-30

Review 3.  Tumour fatty acid metabolism in the context of therapy resistance and obesity.

Authors:  Andrew J Hoy; Shilpa R Nagarajan; Lisa M Butler
Journal:  Nat Rev Cancer       Date:  2021-08-20       Impact factor: 60.716

Review 4.  Potential of electron transfer and its application in dictating routes of biochemical processes associated with metabolic reprogramming.

Authors:  Ronghui Yang; Guoguang Ying; Binghui Li
Journal:  Front Med       Date:  2021-07-24       Impact factor: 4.592

Review 5.  Tumour metabolism and its unique properties in prostate adenocarcinoma.

Authors:  David A Bader; Sean E McGuire
Journal:  Nat Rev Urol       Date:  2020-02-28       Impact factor: 14.432

Review 6.  Skeletal Muscle-Adipose Tissue-Tumor Axis: Molecular Mechanisms Linking Exercise Training in Prostate Cancer.

Authors:  Sílvia Rocha-Rodrigues; Andreia Matos; José Afonso; Miguel Mendes-Ferreira; Eduardo Abade; Eduardo Teixeira; Bruno Silva; Eugenia Murawska-Ciałowicz; Maria José Oliveira; Ricardo Ribeiro
Journal:  Int J Mol Sci       Date:  2021-04-25       Impact factor: 5.923

Review 7.  FABP5 as a novel molecular target in prostate cancer.

Authors:  Saoirse Elizabeth O'Sullivan; Martin Kaczocha
Journal:  Drug Discov Today       Date:  2020-09-20       Impact factor: 7.851

Review 8.  Fatty Acid Synthesis in Prostate Cancer: Vulnerability or Epiphenomenon?

Authors:  Laura A Sena; Samuel R Denmeade
Journal:  Cancer Res       Date:  2021-06-18       Impact factor: 12.701

9.  Adipocyte-driven unfolded protein response is a shared transcriptomic signature of metastatic prostate carcinoma cells.

Authors:  Mackenzie K Herroon; Shane Mecca; Alex Haimbaugh; Laimar C Garmo; Erandi Rajagurubandara; Sokol V Todi; Tracie R Baker; Izabela Podgorski
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2021-07-16       Impact factor: 5.011

Review 10.  Monoacylglycerol lipase reprograms lipid precursors signaling in liver disease.

Authors:  Matteo Tardelli
Journal:  World J Gastroenterol       Date:  2020-07-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.